6505--Dimethyl Fumarate Capsules

The contract under solicitation number 36E79726R0003 pertains to the supply of Dimethyl Fumarate delayed-release capsules for federal healthcare agencies, including the Department of Veterans Affairs and Department of Defense. It is structured as a firm-fixed-price contract with one base year plus four optional one-year periods, and the award will be made in the aggregate for all line items, which include specified quantities of capsules in different sizes. The procurement is unrestricted under NAICS code 325412, and the contract emphasizes strict packaging, labeling, and bar-coding standards, requiring products to meet FDA cGMP standards, incorporate GS1-128 or HIBC bar codes, and be packaged in bottles with safety caps and specific label dimensions. The delivery points are multiple Prime Vendor distribution centers, with inspection and acceptance occurring at the government’s destination facilities. The solicitation process involves detailed evaluation criteria prioritizing technical acceptability, price, and past performance, with award based on the lowest price technically acceptable offer. Offerors must submit proposals via email in PDF or Word format, including signed SF-1449 forms, and provide all required representations, including Unique Entity ID, CAGE code, and compliance with socioeconomic and small business requirements. The contract incorporates numerous FAR and VAAR clauses covering terms and conditions, security, compliance, and prohibitions on certain telecommunications and surveillance equipment. Payment will be made electronically, with a 0.5% Cost Recovery Fee included in prices, and invoices must contain detailed information for processing. The performance period begins upon contract award, with delivery and performance requirements specified for each order, and the contractor is responsible for ensuring products meet all quality standards, including FDA inspections and corrective actions if deficiencies are identified. Overall, the contract emphasizes compliance with federal standards, strict packaging and labeling protocols, and a competitive, transparent procurement process to ensure the reliable supply of pharmaceutical capsules to support federal healthcare operations.